Genome Web Breaking News
- Lunaphore Technologies, Cell Signaling Technology Partner on Antibody-Based Spatial Proteomics
- North African Agriculture Influenced by Incoming Neolithic Populations From Europe, the Levant
- Lyric, Concert Genetics Partner to Improve Genetic Testing Claims Payment Accuracy
- Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis
- Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals
Stat
- How the public health lessons of Covid can help Americans protect themselves from wildfire smoke
- CDC comes under fire for inadequate information about its Covid response
- STAT+: ‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders
- STAT+: After missing vaccine glory in pandemic, GSK looks to dominate other diseases
- STAT+: While other states, countries have biotech envy, Massachusetts can’t find enough workers
NYT science news
- NASA’s Parker Solar Probe Finds Solar Wind Clues
- The Vaquita Hangs On: Drone Video Shows a Critically Endangered Porpoise in Mexico
- Air Quality This Week Gives U.S. a Glimpse of the World’s Air Pollution
- Scientists Discover a Virgin Birth in a Crocodile
- Birds With a Taste for Flesh Threaten Whale Calves
Fierce Biotech
- Cue Health racks up FDA's first de novo nod for an at-home COVID test
- ASCO: Astellas exec jokes that 3 pending drug approvals are turning his hair gray
- FibroGen faces more trouble in clinic as DMD drug fails phase 3 trial
- BIO: Moderna to test mpox vaccine in humans this summer
- Bayer bags access to gene editing delivery tech from biotech behind Pfizer's COVID-19 vaccine
Fierce Medical Devices
- Cue Health racks up FDA's first de novo nod for an at-home COVID test
- Abiomed faces Class I recall of potentially leaky Impella heart pumps
- 400 Grail blood test users were incorrectly told they may have cancer: report
- ASCO: Novocure's tumor-treating electric fields nearly double survival for some lung cancer patients
- FDA collects another 6,000 complaints—including 40 deaths—linked to Philips’ CPAP recall